196 related articles for article (PubMed ID: 28411188)
61. RKIP mediates autoimmune inflammation by positively regulating IL-17R signaling.
Lin W; Wang N; Zhou K; Su F; Jiang Y; Shou J; Liu H; Ma C; Qian Y; Wang K; Wang X
EMBO Rep; 2018 Jun; 19(6):. PubMed ID: 29674348
[TBL] [Abstract][Full Text] [Related]
62. RKIP regulates MAP kinase signaling in cells with defective B-Raf activity.
Zeng L; Ehrenreiter K; Menon J; Menard R; Kern F; Nakazawa Y; Bevilacqua E; Imamoto A; Baccarini M; Rosner MR
Cell Signal; 2013 May; 25(5):1156-65. PubMed ID: 23416466
[TBL] [Abstract][Full Text] [Related]
63. Raf kinase inhibitor protein RKIP enhances signaling by glycogen synthase kinase-3β.
Al-Mulla F; Bitar MS; Al-Maghrebi M; Behbehani AI; Al-Ali W; Rath O; Doyle B; Tan KY; Pitt A; Kolch W
Cancer Res; 2011 Feb; 71(4):1334-43. PubMed ID: 21303975
[TBL] [Abstract][Full Text] [Related]
64. Glucocorticoids inhibit IRF3 phosphorylation in response to Toll-like receptor-3 and -4 by targeting TBK1 activation.
McCoy CE; Carpenter S; Pålsson-McDermott EM; Gearing LJ; O'Neill LA
J Biol Chem; 2008 May; 283(21):14277-85. PubMed ID: 18356163
[TBL] [Abstract][Full Text] [Related]
65. Protein kinase C-mediated phosphorylation of RKIP regulates inhibition of Na-alanine cotransport by leukotriene D(4) in intestinal epithelial cells.
Arthur S; Sundaram U
Am J Physiol Cell Physiol; 2014 Dec; 307(11):C1010-6. PubMed ID: 25231108
[TBL] [Abstract][Full Text] [Related]
66. A new p53 target gene, RKIP, is essential for DNA damage-induced cellular senescence and suppression of ERK activation.
Lee SJ; Lee SH; Yoon MH; Park BJ
Neoplasia; 2013 Jul; 15(7):727-37. PubMed ID: 23814485
[TBL] [Abstract][Full Text] [Related]
67. Raf kinase inhibitor protein (RKIP) dimer formation controls its target switch from Raf1 to G protein-coupled receptor kinase (GRK) 2.
Deiss K; Kisker C; Lohse MJ; Lorenz K
J Biol Chem; 2012 Jul; 287(28):23407-17. PubMed ID: 22610096
[TBL] [Abstract][Full Text] [Related]
68. Raf kinase inhibitory protein is required for cerebellar long-term synaptic depression by mediating PKC-dependent MAPK activation.
Yamamoto Y; Lee D; Kim Y; Lee B; Seo C; Kawasaki H; Kuroda S; Tanaka-Yamamoto K
J Neurosci; 2012 Oct; 32(41):14254-64. PubMed ID: 23055494
[TBL] [Abstract][Full Text] [Related]
69. Pim1 promotes IFN-β production by interacting with IRF3.
Ko R; Seo J; Park H; Lee N; Lee SY
Exp Mol Med; 2022 Nov; 54(11):2092-2103. PubMed ID: 36446848
[TBL] [Abstract][Full Text] [Related]
70. IRAK1 Limits TLR3/4- and IFNAR-Driven IL-27 Production through a STAT1-Dependent Mechanism.
Bruni D; Dignam A; Dunne S; Wall-Coughlan D; McCrudden A; O'Connell K; Lyons C; McGuigan C; Tubridy N; Butler MP
J Immunol; 2018 Oct; 201(7):2070-2081. PubMed ID: 30143585
[TBL] [Abstract][Full Text] [Related]
71. Caspases are key regulators of inflammatory and innate immune responses mediated by TLR3 in vivo.
Shaalan A; Carpenter G; Proctor G
Mol Immunol; 2018 Feb; 94():190-199. PubMed ID: 29331803
[TBL] [Abstract][Full Text] [Related]
72. Raf kinase inhibitor RKIP inhibits MDA-9/syntenin-mediated metastasis in melanoma.
Das SK; Bhutia SK; Sokhi UK; Azab B; Su ZZ; Boukerche H; Anwar T; Moen EL; Chatterjee D; Pellecchia M; Sarkar D; Fisher PB
Cancer Res; 2012 Dec; 72(23):6217-26. PubMed ID: 23066033
[TBL] [Abstract][Full Text] [Related]
73. RKIP suppresses the influenza A virus‑induced airway inflammatory response via the ERK/MAPK pathway.
Ye JJ; Wei SL; Wei YY; Zhang DW; Sun L; Wu HM; Shen JL; Yu L; Wang Y; Fei GH
Int J Mol Med; 2023 Jan; 51(1):. PubMed ID: 36382638
[TBL] [Abstract][Full Text] [Related]
74. RKIP contributes to IFN-γ synthesis by CD8+ T cells after serial TCR triggering in systemic inflammatory response syndrome.
Wright KT; Vella AT
J Immunol; 2013 Jul; 191(2):708-16. PubMed ID: 23761631
[TBL] [Abstract][Full Text] [Related]
75. Heterozygous TBK1 mutations impair TLR3 immunity and underlie herpes simplex encephalitis of childhood.
Herman M; Ciancanelli M; Ou YH; Lorenzo L; Klaudel-Dreszler M; Pauwels E; Sancho-Shimizu V; Pérez de Diego R; Abhyankar A; Israelsson E; Guo Y; Cardon A; Rozenberg F; Lebon P; Tardieu M; Heropolitanska-Pliszka E; Chaussabel D; White MA; Abel L; Zhang SY; Casanova JL
J Exp Med; 2012 Aug; 209(9):1567-82. PubMed ID: 22851595
[TBL] [Abstract][Full Text] [Related]
76. Interactions of RKIP with inflammatory signaling pathways.
Zhao J; Wenzel S
Crit Rev Oncog; 2014; 19(6):497-504. PubMed ID: 25597359
[TBL] [Abstract][Full Text] [Related]
77. Possible role of RKIP in cytotrophoblast migration: immunohistochemical and in vitro studies.
Ciarmela P; Marzioni D; Islam MS; Gray PC; Terracciano L; Lorenzi T; Todros T; Petraglia F; Castellucci M
J Cell Physiol; 2012 May; 227(5):1821-8. PubMed ID: 21732351
[TBL] [Abstract][Full Text] [Related]
78. Systemic LPS induces toll-like receptor 3 (TLR3) expression and apoptosis in testicular mouse tissue.
Nejsum LN; Piec A; Fijak M; Ernstsen CV; Fischer D; Maier TJ; Kinscherf R; Hofmann R; Urbschat A
Cell Tissue Res; 2019 Oct; 378(1):143-154. PubMed ID: 30989399
[TBL] [Abstract][Full Text] [Related]
79. Frequent loss of RAF kinase inhibitor protein expression in acute myeloid leukemia.
Zebisch A; Wölfler A; Fried I; Wolf O; Lind K; Bodner C; Haller M; Drasche A; Pirkebner D; Matallanas D; Rath O; Blyth K; Delwel R; Taskesen E; Quehenberger F; Kolch W; Troppmair J; Sill H
Leukemia; 2012 Aug; 26(8):1842-9. PubMed ID: 22388727
[TBL] [Abstract][Full Text] [Related]
80. Cilia movement regulates expression of the Raf-1 kinase inhibitor protein.
Sas KM; Janech MG; Favre E; Arthur JM; Bell PD
Am J Physiol Renal Physiol; 2011 May; 300(5):F1163-70. PubMed ID: 21345975
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
